UK markets close in 3 hours 59 minutes
  • FTSE 100

    6,399.74
    +65.90 (+1.04%)
     
  • FTSE 250

    19,747.62
    +165.27 (+0.84%)
     
  • AIM

    1,033.14
    -1.90 (-0.18%)
     
  • GBP/EUR

    1.1228
    -0.0024 (-0.22%)
     
  • GBP/USD

    1.3326
    +0.0004 (+0.03%)
     
  • BTC-GBP

    14,337.19
    +491.04 (+3.55%)
     
  • CMC Crypto 200

    376.95
    +15.52 (+4.29%)
     
  • S&P 500

    3,577.59
    +20.05 (+0.56%)
     
  • DOW

    29,591.27
    +327.79 (+1.12%)
     
  • CRUDE OIL

    43.46
    +0.40 (+0.93%)
     
  • GOLD FUTURES

    1,810.60
    -27.20 (-1.48%)
     
  • NIKKEI 225

    26,165.59
    +638.22 (+2.50%)
     
  • HANG SENG

    26,588.20
    +102.00 (+0.39%)
     
  • DAX

    13,250.07
    +123.10 (+0.94%)
     
  • CAC 40

    5,560.02
    +67.87 (+1.24%)
     

Monogram Health Announces NCQA Population Health Program Accreditation

·3-min read

Monogram Health demonstrates commitment to quality and population health-based care model through receipt of NCQA accreditation

Monogram Health announced today that the organization has received Population Health Program accreditation from NCQA, in furtherance of part of the company’s value-based kidney care management services. Achieving NCQA accreditation underscores Monogram Health’s dedication to population health management, improved outcomes, and continuous quality improvement for health plan members suffering from chronic kidney disease and end stage renal disease. NCQA issued the accreditation following a detailed review of the company’s operational processes, clinical care management policies and other practices.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201020005241/en/

"Achieving NCQA accreditation is a testament to the quality work Monogram Health does each day to serve the needs of our members, providers, and health plan clients," said Dr. Raymond Hakim, Monogram’s Chief Medical Officer. "By leveraging our in-home care model, evidence-based clinical criteria and advanced analytics, we are able to drive improved outcomes and reduce unnecessary costs."

Monogram uses its advanced, proprietary artificial intelligence systems to identify the potential care needs of patients with kidney disease. Monogram’s care team – made up of nurse care managers and social workers – partners with nephrologists to ensure medication and treatment compliance and adherence to evidence-based care pathways. The specialized care team also assesses health drivers, such as appropriate nutrition, exercise and other social determinants of health, through regular visits with patients in their homes.

NCQA is an independent, not-for-profit organization dedicated to assessing and reporting on the quality of managed care plans, managed behavioral healthcare organizations, preferred provider organizations, new health plans, physician organizations, credentials verification organizations, disease management programs and other health-related programs.

"The Population Health Management programs moves us in greater alignment with the increased focus on person-centered population health management," said Margaret E. O’Kane, President, NCQA. "Not only does it add value to existing quality improvement efforts, it also demonstrates an organization’s highest level of commitment to improving the quality of care that meets people’s needs."

About Monogram Health

Monogram Health is a leading kidney-disease focused managed services company. It provides an innovative renal care model and data-driven array of care management solutions including complex case and disease management, utilization management and medication therapy management to transform the delivery of care received by patients living with chronic kidney and end-stage renal disease. Partnering with health plans, physician practices, dialysis providers and clinically integrated health systems, Monogram Health provides patients with exceptional at-home individualized care management. Through the use of next generation artificial intelligence, evidence based criteria and personalized care planning, Monogram Health’s model seeks to delay the progression of the disease, promote a seamless transition to dialysis, palliative care and/or pre-emptive kidney transplant and optimize health outcomes for patients with end-stage renal disease. Based in Nashville, Tenn. and privately held by Frist Cressey Ventures and Norwest Venture Partners, Monogram Health currently operates its renal disease care management programs across the U.S. and has built a national network of nephrologists that includes hundreds of leading kidney care specialists. To learn more about Monogram Health, please visit here.

About NCQA

NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. NCQA’s website (ncqa.org) contains information to help consumers, employers and others make more informed health care choices. NCQA can be found online at ncqa.org, on Twitter@ncqa, on Facebook at facebook.com/NCQA.org and on LinkedIn at linkedin.com/company/ncqa.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201020005241/en/

Contacts

Sheila Biggs
312.837.3458
sbiggs@jarrardinc.com